Insulet
PODD
#1005
Rank
C$28.05 B
Marketcap
$399.29
Share price
1.80%
Change (1 day)
75.19%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): C$0.45 Billion

According to Insulet's latest financial reports the company's current earnings are C$1.98 Billion. In 2023 the company made an earning of C$0.36 Billion, an increase over its 2022 earnings that were of C$62.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.45 B25.75%
2023 C$0.36 B481.9%
2022 C$62.08 M-45.24%
2021 C$0.11 B43.35%
2020 C$79.08 M18.51%
2019 C$66.73 M41.16%
2018 C$47.27 M-711.95%
2017 -C$7.73 Million-56.85%
2016 -C$17.91 Million-79.31%
2015 -C$86.56 Million63.85%
2014 -C$52.83 Million31.04%
2013 -C$40.32 Million-21.96%
2012 -C$51.67 Million
2010 -C$49.28 Million-42.38%
2009 -C$85.52 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$77.57 Million209.75%
2006 -C$25.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$5.55 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.18 Billion-136.81%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.04 B 115.77%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.12 B 5,069.53%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.76 B 1,908.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.52 B 1,654.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$18.26 B 3,658.27%๐Ÿ‡บ๐Ÿ‡ธ USA